Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Frode Lerang, René Holst, Magne Henriksen, Henrik Wåhlberg & Lars-Petter Jelsness-Jørgensen. (2022) Antitumour necrosis factor alpha treatment in Crohn’s disease: long-term efficacy, side effects and need for surgery. Scandinavian Journal of Gastroenterology 57:8, pages 921-929.
Read now
Read now
Tero Ylisaukko-oja, Minna Puttonen, Jari Jokelainen, Mirkka Koivusalo, Klaus Tamminen, Saku Torvinen & Markku Voutilainen. (2022) Dose–escalation of adalimumab, golimumab or ustekinumab in inflammatory bowel diseases: characterization and implications in real-life clinical practice. Scandinavian Journal of Gastroenterology 57:4, pages 415-423.
Read now
Read now
Arianna Dal Buono, Giulia Roda, Marjorie Argollo, Eirini Zacharopoulou, Laurent Peyrin-Biroulet & Silvio Danese. (2020) Treat to target or ‘treat to clear’ in inflammatory bowel diseases: one step further?. Expert Review of Gastroenterology & Hepatology 14:9, pages 807-817.
Read now
Read now
Articles from other publishers (5)
Ajit Sood, Arshdeep Singh, Ramit Mahajan, Vandana Midha, Charles N Bernstein & David T Rubin. (2023) (Re)Appraising Remission in Ulcerative Colitis. Inflammatory Bowel Diseases 29:8, pages 1317-1326.
Crossref
Crossref
Reham Saleh Aljohani, Ali Alaklabi, Yumna Mohammed Alsitary, Majd Abdulrahman bin Khunayn, Shahd Omar Hijazi, Rema Ibraheem Alshagary & Rajkumar Rajendram. (2022) Clinical profile, course and outcomes of adults with inflammatory bowel disease over a decade: a single center experience. Annals of Saudi Medicine 42:6, pages 397-407.
Crossref
Crossref
F Magro, J Sabino, F Rosini, M Tripathi, P Borralho, P Baldin, S Danese, A Driessen, I O Gordon, M Iacucci, N Noor, M Svrcek, L Peyrin-Biroulet & R Feakins. (2022) ECCO Position on Harmonisation of Crohn’s Disease Mucosal Histopathology. Journal of Crohn's and Colitis 16:6, pages 876-883.
Crossref
Crossref
N Viazis, C Pontas, A Manolakis, G Karampekos, E Tsoukali, M Galanopoulos, K Koustenis, E Archavlis, A Christidou, M Gazouli & G. J. Mantzaris. (2021) Efficacy of switching from infliximab to golimumab in patients with ulcerative colitis in deep remission. Acta Gastro Enterologica Belgica 84:3, pages 423-428.
Crossref
Crossref
Giuseppe Biscaglia, Mariano Piazzolla, Francesco Cocomazzi, Gennaro Melchionda, Angelo De Cata, Fabrizio Bossa, Orazio Palmieri & Angelo Andriulli. (2020) Landmarks for dual biological therapy in inflammatory bowel disease: lesson from two case reports of vedolizumab in combination with ustekinumab. European Journal of Gastroenterology & Hepatology 32:12, pages 1579-1582.
Crossref
Crossref